Enrico Vanni

Former Head, European Pharmaceutical Practice at Mckinsey & Co. (Zurich)

Enrico Vanni

Enrico Vanni

Former Head, European Pharmaceutical Practice at Mckinsey & Co. (Zurich)

Overview
RelSci Relationships

284

Number of Boards

11

Birthday

1951

Age

69

Contact Data
Trying to get in touch with Enrico Vanni? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Enrico Vanni likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Operating Officer at Novartis AG

Relationship likelihood: Strong

Head of the Novartis Vaccines & Diagnostics Division at Novartis Corporation

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Advanced Oncotherapy Plc

Relationship likelihood: Strong

Executive Chairman Adam S.A at Advanced Oncotherapy Plc

Relationship likelihood: Strong

Executive Chairman at Advanced Oncotherapy Plc

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Partner at Lenz & Staehelin AG

Relationship likelihood: Strong

Senior Vice President of Finance at Unilever PLC

Relationship likelihood: Strong

Paths to Enrico Vanni
Potential Connections via
Relationship Science
You
Enrico Vanni
Former Head, European Pharmaceutical Practice at Mckinsey & Co. (Zurich)
Education
Engineering Degree in Chemistry

EPFL is Europe’s most cosmopolitan technical university with students, professors and staff from over 120 nations. A dynamic environment, open to Switzerland and the world, EPFL is centered on its three missions: teaching, research and technology transfer. EPFL works together with an extensive network of partners including other universities and institutes of technology, developing and emerging countries, secondary schools and colleges, industry and economy, political circles and the general public, to bring about real impact for society.

Ph.D. Chemistry

The University of Lausanne is a higher teaching and research institution composed of seven faculties where approximately 14,300 students and 3,000 researchers work and study. UNIL is focused on several academic disciplines, especially Medicine, Life Sciences, Geosciences, Environment, Business, Humanities and Social Sciences. An emphasis is placed on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors.

Master of Business Administration

INSEAD is a graduate business school with campuses in Europe, Asia and the Middle East. INSEAD, widely considered one of the best business schools in the world, allows its students to study in the US (West Coast- San Francisco via Wharton exchange, East Coast- Philadelphia via Wharton exchange, Midwest- Evanston near Chicago via Kellogg exchange), in Asia (Singapore via INSEAD Asia Campus exchange and Shanghai via CEIBS exchange), in the Middle East (Abu Dhabi via INSEAD Middle East Campus exchange) and in Europe (Fontainebleau via INSEAD Europe Campus exchange)

Career History
Research Engineer
Prior

The International Business Machines Corporation (IBM) is an American multinational technology and consulting corporation, with headquarters in Armonk, New York, United States. IBM manufactures and markets computer hardware and software, and offers infrastructure, hosting and consulting services in areas ranging from mainframe computers to nanotechnology.

Boards & Committees
Member, Board of Directors
Current

Denzler & Partner is the consultancy for helps to client how to manage our business, assess the resources etc for develop the business.

Vice Chairman, Board of Directors
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Member, Board of Directors
Current

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Director
Prior

Eclosion Foundation offers researchers managerial and scientific support for their projects, from finance to validation resources. The firm also provides premises, laboratories, and services adapted to the needs of their clients. It focuses on biotechnology and biomedical engineering sectors. The company was founded by Jesús Martin-Garcia and Benoit Dubois and is headquartered in Plan-les-Ouates, Switzerland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Enrico Vanni. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Enrico Vanni's profile does not indicate a business or promotional relationship of any kind between RelSci and Enrico Vanni.